No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Lazzerini et al. (2020) conducted an editorial in COVID-19. IL-6 blockade (tocilizumab, sarilumab) was evaluated.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: